Acetylsalicylic acid Completed Phase 2 Trials for Persistent or Permanent Non-valvular Atrial Fibrillation Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT00623779Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)